5L
BMY icon

55I LLC’s Bristol-Myers Squibb BMY Stock Holding History

55I LLC’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$2.74M Buy
38,540
+25,133
+187% +$1.82M 0.08% 159
2022
Q2 		$1.03M Buy
13,407
+6,589
+97% +$502K 0.03% 256
2022
Q1 		$497K Buy
6,818
+1,252
+22% +$84.1K 0.01% 358
2021
Q4 		$346K Sell
5,566
-6,962
-56% -$408K 0.01% 397
2021
Q3 		$742K Buy
+12,528
New +$825K 0.02% 265

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

55I LLC's BMY Position: Q3 2022 in Review

55I LLC increased its Bristol-Myers Squibb (BMY) stake by 187% in Q3 2022, buying an estimated $1.82M and bringing the position to 38,540 shares worth $2.74M. The position accounts for 0.08% of the portfolio, ranked #159.

55I LLC first reported a position in BMY in Q3 2021 and has held it in 5 quarters since. 2,469 funds tracked by Wall St. Rank hold BMY as of Q3 2022.

  • 55I LLC held 38,540 shares of Bristol-Myers Squibb worth $2.74M as of Q3 2022.
  • 55I LLC bought 25,133 Bristol-Myers Squibb shares in Q3 2022, an estimated $1.82M.
  • Bristol-Myers Squibb made up 0.08% of 55I LLC's portfolio in Q3 2022, its #159 holding.
  • 55I LLC first reported a position in Bristol-Myers Squibb in Q3 2021 and has held it in 5 quarters since.
  • 2,469 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2022.

Based on 55I LLC's 13F filing for Q3 2022, filed 14 Nov 2022.